X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (40) 40
female (32) 32
index medicus (28) 28
oncology (27) 27
middle aged (24) 24
medical and health sciences (23) 23
medicin och hälsovetenskap (23) 23
adult (22) 22
aged (22) 22
hematology (21) 21
clinical medicine (18) 18
klinisk medicin (18) 18
male (16) 16
treatment outcome (15) 15
breast cancer (14) 14
chemotherapy (13) 13
cancer (12) 12
antineoplastic combined chemotherapy protocols - therapeutic use (10) 10
hematologi (10) 10
medicine (10) 10
aged, 80 and over (9) 9
prognosis (9) 9
research (9) 9
rituximab (9) 9
young adult (9) 9
breast neoplasms - drug therapy (8) 8
breast neoplasms - pathology (8) 8
cancer och onkologi (8) 8
survival analysis (8) 8
therapy (8) 8
antineoplastic agents - therapeutic use (7) 7
breast neoplasms - genetics (7) 7
cancer and oncology (7) 7
expression (7) 7
follicular lymphoma (7) 7
medical research (7) 7
metastasis (7) 7
neoplasm staging (7) 7
research article (7) 7
tumors (7) 7
analysis (6) 6
antineoplastic combined chemotherapy protocols - adverse effects (6) 6
genetic aspects (6) 6
neoplasm metastasis (6) 6
survival (6) 6
bone-marrow (5) 5
gene-expression (5) 5
indolent lymphoma (5) 5
lymphomas (5) 5
mutation (5) 5
oncology, experimental (5) 5
patients (5) 5
studies (5) 5
time factors (5) 5
anthracyclines (4) 4
cancer therapies (4) 4
care and treatment (4) 4
chemotherapy, adjuvant (4) 4
cytotoxicity (4) 4
gene mutations (4) 4
genetics (4) 4
health aspects (4) 4
hematopoietic stem cell transplantation - methods (4) 4
immunohistochemistry (4) 4
immunotherapy (4) 4
klinisk medisinske fag: 750 (4) 4
lymphoma, non-hodgkin - blood (4) 4
medicin (4) 4
medisinske fag: 700 (4) 4
neoplasm grading (4) 4
non-hodgkins-lymphoma (4) 4
oncology: 762 (4) 4
onkologi: 762 (4) 4
p53 (4) 4
prospective studies (4) 4
proteins (4) 4
skin and connective tissue diseases (4) 4
tumor proteins (4) 4
vdp (4) 4
activation (3) 3
adjuvant treatment (3) 3
adolescent (3) 3
advanced-stage (3) 3
anthracycline (3) 3
anthracyclines - therapeutic use (3) 3
antibiotics, antineoplastic - therapeutic use (3) 3
antibodies, monoclonal, murine-derived - therapeutic use (3) 3
antineoplastic combined chemotherapy protocols - administration & dosage (3) 3
apoptosis (3) 3
biology (3) 3
biomarkers (3) 3
bone marrow (3) 3
bone marrow - pathology (3) 3
breast neoplasms - diagnosis (3) 3
breast neoplasms - immunology (3) 3
breast neoplasms - mortality (3) 3
cells (3) 3
chronic lymphocytic-leukemia (3) 3
clinical medical disciplines: 750 (3) 3
cohort studies (3) 3
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 09/2012, Volume 30, Issue 25, pp. 3093 - 3099
Journal Article
PLoS ONE, ISSN 1932-6203, 2011, Volume 6, Issue 4, p. e19249
Background: TP53 mutations have been associated with resistance to anthracyclines but not to taxanes in breast cancer patients. The MDM2 promoter single... 
APOPTOSIS | NEOADJUVANT TREATMENT | GENE | SNP309 | IN-VIVO | BIOLOGY | POLYMORPHISM | SYSTEMIC THERAPY | CONTRIBUTES | EXPRESSION | P53 | Promoter Regions, Genetic | Proto-Oncogene Proteins c-mdm2 - genetics | Prognosis | Humans | Genotype | Antineoplastic Agents - therapeutic use | Epirubicin - administration & dosage | DNA Primers | Breast Neoplasms - drug therapy | Genes, p53 | Breast Neoplasms - genetics | Base Sequence | Survival Analysis | Female | Polymorphism, Single Nucleotide | Mutation | Paclitaxel - administration & dosage | Cohort Studies | Cancer patients | Chemotherapy | Anthracyclines | Gene mutations | Paclitaxel | Breast cancer | Genetic aspects | Single nucleotide polymorphisms | Tumor proteins | Cancer | Senescence | Impact prediction | p53 Protein | Cytotoxicity | Oncology | Single-nucleotide polymorphism | Metastasis | Gene polymorphism | Cancer therapies | Surgery | Epirubicin | MDM2 protein | Radiation therapy | Patients | Survival | Medicine | Hypotheses | Anthracycline | Experimental design | Breast | Molecular biology | Taxanes | Tumors | Apoptosis | Polymorphism | Medisinsk genetikk: 714 | VDP | Basic medical, dental and veterinary science disciplines: 710 | Oncology: 762 | Klinisk medisinske fag: 750 | Onkologi: 762 | Medical genetics: 714 | Medisinske Fag: 700 | Clinical medical disciplines: 750 | Medical disciplines: 700 | Basale medisinske, odontologiske og veterinærmedisinske fag: 710
Journal Article
British journal of haematology, ISSN 0007-1048, 08/2019
The clinical course of follicular lymphoma (FL) is highly variable. Recently the m7-FL international prognostic index (FLIPI) integrating performance status,... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 2019, Volume 37, Issue 9, pp. 759 - 760
Journal Article
British Journal of Haematology, ISSN 0007-1048, 08/2012, Volume 158, Issue 3, pp. 355 - 362
Journal Article
PLoS ONE, ISSN 1932-6203, 08/2008, Volume 3, Issue 8, p. e3062
Background: Chemoresistance is the main obstacle to cure in most malignant diseases. Anthracyclines are among the main drugs used for breast cancer therapy and... 
BIOLOGY | Promoter Regions, Genetic | Humans | Protein-Serine-Threonine Kinases - genetics | Drug Resistance, Neoplasm | Breast Neoplasms - drug therapy | Tumor Suppressor Protein p53 - genetics | Breast Neoplasms - enzymology | DNA Methylation | Breast Neoplasms - genetics | Antibiotics, Antineoplastic - therapeutic use | Breast Neoplasms - pathology | DNA Mutational Analysis | Checkpoint Kinase 2 | Epirubicin - therapeutic use | RNA, Neoplasm - genetics | Female | DNA, Neoplasm - genetics | Mutation | Neoplasm Staging | Anthracyclines | Care and treatment | Oncology, Experimental | Genes | Breast cancer | Research | Drug resistance | Gene expression | Ionizing radiation | Gene mutations | Analysis | Genetic research | Genetic aspects | Tumor proteins | Health aspects | Cancer | Drugs | Therapy | Senescence | p53 Protein | DNA damage | Chemoresistance | Oncology | Metastasis | Kinases | Cancer therapies | Proteins | Cascades | Fibroblasts | Epirubicin | Dimerization | Drug dosages | Deoxyribonucleic acid--DNA | Medical research | Damage assessment | CHK2 protein | Patients | Medicine | Studies | Chemotherapy | Damage detection | Anthracycline | Response rates | Breast | Molecular biology | Tumors | Apoptosis | VDP | Oncology: 762 | Klinisk medisinske fag: 750 | Onkologi: 762 | Medisinske Fag: 700 | Clinical medical disciplines: 750 | Medical disciplines: 700 | Deoxyribonucleic acid | DNA
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 917 - 917
Abstract Background: Follicular lymphoma (FL) is the most common subtype of indolent non Hodgkin's lymphoma (NHL). Median survival is long (>10 years), but... 
Journal Article
Breast Cancer Research, ISSN 1465-5411, 08/2012, Volume 14, Issue 4, pp. R117 - R117
Journal Article
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 06/2008, Volume 99, Issue 6, pp. 1040 - 1048
Summary Patients with haematological malignancies carry increased risk of venous thrombosis (VT). However, the mechanisms that link these malignancies to... 
leukaemia | myeloma | coagulation | lymphoma | Tissue factor | Blood Coagulation, Fibrinolysis and Cellular Haemostasis | Myeloma | Lymphoma | Coagulation | Leukaemia | CELLS | tissue factor | RESPONSE CRITERIA | MALIGNANT-LYMPHOMA | ACUTE MYELOID-LEUKEMIA | CANCER | WORKING GROUP | HEMOSTATIC ABNORMALITIES | VENOUS THROMBOEMBOLISM | DISSEMINATED INTRAVASCULAR COAGULATION | CHRONIC LYMPHOCYTIC-LEUKEMIA | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | Hematologic Neoplasms - therapy | Fibrin Fibrinogen Degradation Products - metabolism | Humans | Middle Aged | Venous Thrombosis - blood | Male | Leukemia, Lymphocytic, Chronic, B-Cell - complications | Leukemia, Myeloid, Acute - complications | Case-Control Studies | Thrombophilia - etiology | Lymphoma, Non-Hodgkin - complications | Lymphoma, Non-Hodgkin - blood | Peptide Fragments - blood | Aged, 80 and over | Adult | Female | Leukemia, Lymphocytic, Chronic, B-Cell - blood | Hematologic Neoplasms - complications | Multiple Myeloma - blood | Thrombophilia - genetics | Multiple Myeloma - complications | Factor VII - metabolism | Glycoproteins - blood | Leukemia, Myeloid, Acute - blood | Biomarkers - blood | Lipoproteins - blood | Venous Thrombosis - etiology | RNA, Messenger - blood | Hematologic Neoplasms - blood | Thrombophilia - blood | Norway | Prothrombin | Blood Coagulation - genetics | Aged | Hematologic Neoplasms - genetics | Venous Thrombosis - genetics | Thromboplastin - metabolism | Longitudinal Studies
Journal Article
ISSN 1078-0432, 2017
Purpose: T cells infiltrating follicular lymphoma (FL) tumors are considered dysfunctional, yet the optimal target for immune checkpoint blockade is unknown.... 
Journal Article
British Journal of Haematology, ISSN 0007-1048, 10/2016, Volume 175, Issue 1, pp. 102 - 114
Journal Article